Clinical Evidence Comparison: What Research Shows
Which Is Best Mounjaro or Wegovy: Understanding the Clinical Evidence
When evaluating which is best Mounjaro or Wegovy for UK patients, clinical trial evidence provides the foundation for informed decision-making. Wegovy's efficacy is demonstrated through the comprehensive STEP trial programme, with STEP 1 showing ~15% average weight loss at 68 weeks when used alongside diet and exercise interventions. The STEP 3 trial achieved ~16% average weight loss when combined with intensive behavioural therapy, whilst STEP 5 demonstrated sustained results of ~15.2% at two years (Wilding et al., NEJM, 2021).
Mounjaro's clinical evidence comes from the SURMOUNT trials, utilising a different dual-agonist mechanism targeting both GIP and GLP-1 receptors compared to Wegovy's GLP-1-only approach. Both treatments require prescription-only access through qualified healthcare providers, and the decision of which is best Mounjaro or Wegovy ultimately depends on individual patient factors assessed during clinical consultation.
Pricing and Value: Which Is Best Mounjaro or Wegovy Financially
Understanding the cost implications helps determine which is best Mounjaro or Wegovy for your budget considerations. Wegovy pricing at EverydayMeds starts with the 0.25mg starter dose at £79.99, progressing through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), to the maintenance 2.4mg dose (£209.99). New customers benefit from discount code FIRST40 applied at checkout, whilst returning customers use code DOSE25.
Bundle options provide convenience for treatment continuity, including the Intro Duo (0.25mg & 0.5mg) for £169.99 and the Progress Trio (0.5mg, 1mg & 1.7mg) at £369.99. The Ultimate Stability Trio offers three months of maintenance 2.4mg supply for £649.99, ensuring uninterrupted treatment progression. Both Mounjaro and Wegovy require similar dose escalation protocols, making direct cost comparison an important factor when deciding which is best Mounjaro or Wegovy for long-term treatment.
Mechanism Differences: Which Is Best Mounjaro or Wegovy Scientifically
The fundamental distinction when considering which is best Mounjaro or Wegovy lies in their biological mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the natural incretin hormone responsible for appetite regulation and glucose homeostasis. This mechanism promotes satiety, reduces food intake, and may help diminish cravings by acting on brain appetite centres.
Mounjaro utilises tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist, potentially offering enhanced metabolic effects through this combined approach. The choice of which is best Mounjaro or Wegovy may depend on how individuals respond to single versus dual receptor targeting, though both mechanisms support weight management when used alongside reduced-calorie diet and increased physical activity.
How Wegovy Works in Practice
Wegovy functions as a GLP-1 receptor agonist, replicating the effects of naturally occurring incretin hormones that regulate appetite and food intake after meals. The medication binds to GLP-1 receptors in the brain's appetite control centres, promoting feelings of fullness and reducing the desire to eat between meals. This mechanism may help patients feel satisfied with smaller portion sizes whilst potentially reducing cravings for high-calorie foods. The once-weekly injection schedule using the FlexTouch pen device provides consistent therapeutic levels throughout the treatment period. Clinical studies suggest these effects, combined with lifestyle modifications, can support meaningful weight management outcomes over extended periods.
EverydayMeds Ordering Process
Our streamlined approach removes complexity from accessing prescription weight management treatments through our GPhC-registered pharmacy (#9012878). The process begins with a comprehensive 3-minute online clinical assessment covering medical history, current medications, and treatment goals to ensure suitability. Qualified prescribers review each application within 3 working days (24-hour express option available), evaluating individual circumstances to determine appropriate treatment recommendations. Once approved, medications are dispatched via next-day delivery using specialist cold-chain transportation to maintain therapeutic integrity. This regulated approach ensures patient safety whilst providing convenient access to prescription-only medicines under proper medical supervision.
Storage and Practical Considerations
Practical factors often influence which is best Mounjaro or Wegovy for individual lifestyles, particularly regarding storage requirements and travel considerations. Wegovy must be stored in the refrigerator at 2-8°C before first use, but offers significant flexibility once removed, remaining stable at room temperature below 30°C for up to 6 weeks. This storage advantage over Mounjaro's 21-day room temperature limit makes Wegovy more suitable for frequent travellers or those with variable schedules. The FlexTouch pen design provides user-friendly injection experience with clear dose indication and safety features. Mandatory dose escalation from 0.25mg through to maintenance 2.4mg over 16 weeks allows gradual adaptation and side effect management. Both treatments require consistent weekly administration for optimal therapeutic benefit.
UK-Specific Weight Loss Results: Which Is Best Mounjaro or Wegovy
UK patients considering which is best Mounjaro or Wegovy benefit from NICE guidance TA875 recommending Wegovy alongside specialist weight management support for eligible individuals. The SELECT cardiovascular outcomes trial demonstrated 20% reduction in major adverse cardiovascular events, providing additional health benefits beyond weight management for appropriate patients. This evidence particularly resonates with UK healthcare priorities focusing on cardiovascular disease prevention and long-term health outcomes.
Real-world UK prescribing patterns suggest both treatments can be effective when properly supervised, though individual responses vary significantly based on genetic factors, lifestyle adherence, and concurrent medical conditions. The question of which is best Mounjaro or Wegovy ultimately requires personalised clinical assessment considering BMI, comorbidities, previous treatment responses, and patient preferences regarding injection frequency and storage requirements.
Making Your Decision: Expert Guidance Available
Both Wegovy and Mounjaro are available from EverydayMeds, with expert prescriber guidance helping determine which option aligns best with individual circumstances and treatment goals. Our clinical team evaluates multiple factors including medical history, lifestyle considerations, storage preferences, and cost implications when recommending appropriate therapy. The decision process considers contraindications, drug interactions, and realistic expectation setting based on clinical trial evidence and real-world outcomes. Ongoing support ensures treatment optimisation and side effect management throughout the dose escalation period and maintenance therapy. Start your assessment today using discount codes FIRST40 (new customers) or DOSE25 (returning customers) applied at checkout for immediate savings on your chosen treatment pathway.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
